• Quarterly revenue of $1.96 million, demonstrating resilience
• Record monthly sales of $1.2 million in March
• United States revenue increased 11% QoQ to $1.15 million

The Calmer Co. International Limited (ASX: CCO) reported revenue of $1.96 million for Q3 FY26, broadly in line with the prior quarter. Performance was impacted by temporary retail channel disruption and the timing of wholesale shipments, with growth in wholesale and B2B channels partially offsetting this impact. The United States continued to lead the company's growth, now contributing 59% of Group revenue, supported by strong partner demand and expanding distribution across e-commerce and wholesale. Wholesale revenue increased 78% QoQ to $645,783, reflecting increasing demand for both traditional kava formats and high-potency CO2 extracts. The company also achieved a new record monthly sales result of $1.2 million in March, demonstrating the increasing scale and repeatability of its wholesale order cycle. With a strengthened balance sheet following a recent capital raise, The Calmer Co. is well positioned to execute its growth strategy and progress toward cash flow breakeven.

Based on current operating performance and available funding, the Board expects the company to continue executing its growth strategy and progressing toward cash flow breakeven.

The Calmer Co. enters Q4 FY26 supported by record monthly sales, continued growth in U.S. wholesale and B2B channels, and a strengthened balance sheet. The company remains focused on cost management and working capital discipline as it scales.